Shilpa Pharma Lifesciences Earns Top Marks In Global Quality Audit By ANVISA-Brazil

Shilpa Medicare Limited's subsidiary, Shilpa Pharma Lifesciences Limited, located at Raichur in Karnataka, has recently undergone a GMP inspection by ANVISA-Brazil from April 15 to April 19, 2024. Following a successful inspection, the facility has been awarded GMP Certification by ANVISA-Brazil. Specializing in manufacturing oncology and non-oncology APIs, the unit maintains a steadfast commitment to upholding GMP standards and quality norms set by Global Regulatory Authorities.